This study will investigate whether a non-surgical treatment option will provide patients with comparable ankle function and quality of life to those treated with surgery.
Both treatments are used across the NHS currently and are not new or experimental.
In this study we use a process called randomisation, which means you cannot choose which treatment you have.
If you decide you would like to be involved in the study you will be asked to sign a consent form.
The only additional commitment we would ask of you would be to fill out a questionnaire at the start of treatment and on three occasions during your recovery.
As you have broken your ankle you are eligible to be a part of this study.
This study is expected to last 8 years. At the end of the study we will publish the findings in medical journals and at medical conferences.
Do you have any questions about the FAME study? It’s important that you ask us about anything you aren’t sure of.
Email the chief investigator:
Contacts for further information
If, at any time, you would like further information about this study you may contact the Trial Manager by telephoning 01865 223123. Or you can contact your local research lead or Associate Professor Xavier Griffin, who is the overall lead of this study on 01865 223123.
The PALS service (PASS in Scotland) is a confidential NHS service that can provide you with support for any complaints or queries you may have regarding the care you receive as an NHS patient. PALS and PASS can give general advice, however they will not be able to give specific information regarding this study.
Frequently asked questions
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that are not necessary for the website to function are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.